During a live event, Alexander I. Spira, MD, PhD, and participants NGS testing practices and the rationale behind their ...

Predicting how cancer patients will respond to treatment remains a critical challenge. Immune checkpoint inhibitors (ICIs), a ...

Recombinant human TSH (rhTSH) was developed to provide TSH stimulation without the requirement for THST withdrawal and the ...

Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: ...

Rising Demand for Precision Medicine and Advancements in Genomic Technologies Drive Market GrowthPune, Feb. 18, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Personalized Medicine Biomarkers ...

Colorectal cancer (CRC), which affects the colon or rectum, represents a significant public health challenge. It ranks as the ...

近日，NMPA官网发布重磅消息，神州细胞自主研发的1类新药菲诺利单抗（商品名：安佑平）正式获批上市。此次获批的适应症为与含铂化疗联合，用于复发性和/或转移性头颈部鳞状细胞癌的一线治疗。 据悉，这是首个获批头颈部鳞癌适应症的国产PD-1药物。 1 ...

Upon Opdualag’s approval in 2022 as a first-in-class cancer immunotherapy, Bristol Myers Squibb was anxious to explore its potential in a variety of indications. | Bristol Myers Squibb is striking out ...

An AI tool appeared superior to two FDA-approved biomarkers for predicting how people with cancer will respond to immune ...

Know about the revolutionary therapies, personalised medicine and cancer treatments that are changing the game!

One of the most significant challenges in cancer treatment is the development of drug resistance by cancer cells, which often ...

This browser is not supported, please use a different one or install the app Ludovic Ajorque is likely to remember the winter of 2025 for a long time! Between the ...